A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
The rapidity with which the new administration is putting in place policies to end DEI programs is sowing fear among ...
AbbVie Inc (NYSE:ABBV)., a leading biopharmaceutical company with a market capitalization of $311.86 billion, has been at the forefront of the industry with its diverse portfolio of pharmaceuticals ...